Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@PharmaEssentia Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::4852899959.png) @PharmaEssentia PharmaEssentia

PharmaEssentia posts on X about $6446tw, vera, pi, mesa the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::4852899959/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4852899959/c:line/m:interactions.svg)

- X Week XXX +6%
- X Month XXX -XX%
- X Months XXXXX +4,030%
- X Year XXXXX +4,849%

### Mentions: X [#](/creator/twitter::4852899959/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4852899959/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::4852899959/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4852899959/c:line/m:followers.svg)

- X Week XXX no change
- X Month XXX +0.17%
- X Months XXX +1.70%
- X Year XXX +6.20%

### CreatorRank: undefined [#](/creator/twitter::4852899959/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::4852899959/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::4852899959/influence)
---

**Social category influence**
[finance](/list/finance) 

**Social topic influence**
[$6446tw](/topic/$6446tw), [vera](/topic/vera), [pi](/topic/pi), [mesa](/topic/mesa)
### Top Social Posts [#](/creator/twitter::4852899959/posts)
---
Top posts by engagements in the last XX hours

"For Buzz advocating for his own health and finding a specialist he could partner with were critical steps following his polycythemia vera diagnosis. Hear Buzz tell the story of his PV journey. Listen to more PV patient stories:"  
![@PharmaEssentia Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::4852899959.png) [@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1948812787154636849) 2025-07-25 18:29:10 UTC XXX followers, XX engagements


"When Steven was diagnosed with polycythemia vera during the pandemic he faced more challenges than he ever expected. In this episode of PV Pod: Stories from the Marrow Steven shares his experiences and how a strong support network helped him through"  
![@PharmaEssentia Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::4852899959.png) [@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1945853167817662508) 2025-07-17 14:28:42 UTC XXX followers, XX engagements


"Looking for a new role Join our team at PharmaEssentia where science and purpose come together to drive patient impact. Were hiring across multiple departments including Commercial R&D Medical BD and more. Explore open positions:"  
![@PharmaEssentia Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::4852899959.png) [@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1947650413999587666) 2025-07-22 13:30:18 UTC XXX followers, XX engagements


"#ASCO25 is only a few weeks away Dr. Ruben Mesa study PI and renowned blood cancer expert will share positive results from our Phase X SURPASS-ET clinical trial in an oral presentation on 6/2. Learn more:"  
![@PharmaEssentia Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::4852899959.png) [@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1924801731935793380) 2025-05-20 12:17:48 UTC XXX followers, XXX engagements


"Today we announced data review results published in the @JCO_ASCO supplement for #ASCO24 demonstrating the potential for cytoreductive therapies (CTs) to impact the burden of illness of #PolycythemiaVera (PV) in patients. Learn more:"  
![@PharmaEssentia Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::4852899959.png) [@PharmaEssentia](/creator/x/PharmaEssentia) on [X](/post/tweet/1795889470924783634) 2024-05-29 18:46:30 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@PharmaEssentia Avatar @PharmaEssentia PharmaEssentia

PharmaEssentia posts on X about $6446tw, vera, pi, mesa the most. They currently have XXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX +6%
  • X Month XXX -XX%
  • X Months XXXXX +4,030%
  • X Year XXXXX +4,849%

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

  • X Week XXX no change
  • X Month XXX +0.17%
  • X Months XXX +1.70%
  • X Year XXX +6.20%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence finance

Social topic influence $6446tw, vera, pi, mesa

Top Social Posts #


Top posts by engagements in the last XX hours

"For Buzz advocating for his own health and finding a specialist he could partner with were critical steps following his polycythemia vera diagnosis. Hear Buzz tell the story of his PV journey. Listen to more PV patient stories:"
@PharmaEssentia Avatar @PharmaEssentia on X 2025-07-25 18:29:10 UTC XXX followers, XX engagements

"When Steven was diagnosed with polycythemia vera during the pandemic he faced more challenges than he ever expected. In this episode of PV Pod: Stories from the Marrow Steven shares his experiences and how a strong support network helped him through"
@PharmaEssentia Avatar @PharmaEssentia on X 2025-07-17 14:28:42 UTC XXX followers, XX engagements

"Looking for a new role Join our team at PharmaEssentia where science and purpose come together to drive patient impact. Were hiring across multiple departments including Commercial R&D Medical BD and more. Explore open positions:"
@PharmaEssentia Avatar @PharmaEssentia on X 2025-07-22 13:30:18 UTC XXX followers, XX engagements

"#ASCO25 is only a few weeks away Dr. Ruben Mesa study PI and renowned blood cancer expert will share positive results from our Phase X SURPASS-ET clinical trial in an oral presentation on 6/2. Learn more:"
@PharmaEssentia Avatar @PharmaEssentia on X 2025-05-20 12:17:48 UTC XXX followers, XXX engagements

"Today we announced data review results published in the @JCO_ASCO supplement for #ASCO24 demonstrating the potential for cytoreductive therapies (CTs) to impact the burden of illness of #PolycythemiaVera (PV) in patients. Learn more:"
@PharmaEssentia Avatar @PharmaEssentia on X 2024-05-29 18:46:30 UTC XXX followers, XXX engagements

creator/x::PharmaEssentia
/creator/x::PharmaEssentia